Geron (GERN) Stock Price
$2.57 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
3 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Geron, AI stock picks, stock alerts and much more.
GERN AI Stock Analysis
AI stock analysis for GERN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron (GERN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Geron (GERN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron (GERN), currently trading at $2.57, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GERN
-
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
-
Symbol
GERN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.6B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
GERN Alternative Data
Web Traffic
Geron receives an estimated 13208 monthly visitors to geron.com.
-
Web Traffic
13208
-
Change from Previous Month
23.5%
-
3 Month Change
36.4%
-
YoY Change
36.4%
News Mentions
Geron was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Geron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
LinkedIn Followers
15,408 are following Geron on LinkedIn, up by 4.7% over the last month.
-
LinkedIn Followers
15408
-
Daily Change
0%
-
1 Month Change
4.7%
-
3 Month Change
11%
Job Postings
Geron currenly has an estimated 10 open job postings, up by 11.1% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
11.1%
-
3 Month Change
42.9%
-
YoY Change
42.9%
LinkedIn Employees
According to LinkedIn, Geron has 382 employees, up by 2.1% over the last month.
-
LinkedIn Employees
382
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
5.5%
-
YoY Change
5.5%
Business Outlook
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
GERN Financials
GERN Key Metrics
-
Total Revenue
$28.3M
-
Net Income
-$26.4M
-
Earnings per Share
-$0.0399
-
Free cash flow
-$58.9M
-
EBITDA
-$23.2M
-
EBITDA Ratio
-0.820629
-
Total Assets
$402.7M
GERN 2-year Revenue & Income
GERN 2-year Free Cash Flow
GERN Technicals
GERN SMA
GERN RSI
FAQ
What's the current price of Geron (GERN) Stock?
The price of an Geron (GERN) share is $2.57.
What's the market cap of Geron?
The current market cap of Geron is 1.6B.
Should I buy or sell GERN?
Geron shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Geron is better viewed as a hold or accumulate position while waiting for further developments.
Is Geron a good investment?
The current analysis of Geron's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Geron's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Geron (GERN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Geron stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Geron (GERN) that investors often compare it to?
Geron (GERN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Geron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron's stock price to be around $2.52 in 2026. Starting from the current price of $2.57, this represents a 2% change in price, indicating a neutral outlook for the stock.
How to buy Geron (GERN) Stock?
Geron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.